337 related articles for article (PubMed ID: 27245063)
1. Identifying significant microRNA-mRNA pairs associated with breast cancer subtypes.
Bhattacharyya M; Nath J; Bandyopadhyay S
Mol Biol Rep; 2016 Jul; 43(7):591-9. PubMed ID: 27245063
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA expression and gene regulation drive breast cancer progression and metastasis in PyMT mice.
Nogales-Cadenas R; Cai Y; Lin JR; Zhang Q; Zhang W; Montagna C; Zhang ZD
Breast Cancer Res; 2016 Jul; 18(1):75. PubMed ID: 27449149
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the miRNA-mRNA-lncRNA network in human estrogen receptor-positive and estrogen receptor-negative breast cancer based on TCGA data.
Xiao B; Zhang W; Chen L; Hang J; Wang L; Zhang R; Liao Y; Chen J; Ma Q; Sun Z; Li L
Gene; 2018 Jun; 658():28-35. PubMed ID: 29518546
[TBL] [Abstract][Full Text] [Related]
5. Prioritizing breast cancer subtype related miRNAs using miRNA-mRNA dysregulated relationships extracted from their dual expression profiling.
Hua L; Zhou P; Li L; Liu H; Yang Z
J Theor Biol; 2013 Aug; 331():1-11. PubMed ID: 23619378
[TBL] [Abstract][Full Text] [Related]
6. Serum-based six-miRNA signature as a potential marker for EC diagnosis: Comparison with TCGA miRNAseq dataset and identification of miRNA-mRNA target pairs by integrated analysis of TCGA miRNAseq and RNAseq datasets.
Sharma P; Saraya A; Sharma R
Asia Pac J Clin Oncol; 2018 Oct; 14(5):e289-e301. PubMed ID: 29380534
[TBL] [Abstract][Full Text] [Related]
7. Competing endogenous RNA network analysis identifies critical genes among the different breast cancer subtypes.
Chen J; Xu J; Li Y; Zhang J; Chen H; Lu J; Wang Z; Zhao X; Xu K; Li Y; Li X; Zhang Y
Oncotarget; 2017 Feb; 8(6):10171-10184. PubMed ID: 28052038
[TBL] [Abstract][Full Text] [Related]
8. Construction of an initial microRNA regulation network in breast invasive carcinoma by bioinformatics analysis.
Yin Y; Shen C; Xie P; Cheng Z; Zhu Q
Breast; 2016 Apr; 26():1-10. PubMed ID: 27017236
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the miRNA-mRNA-lncRNA networks in ER+ and ER- breast cancer cell lines.
Wu Q; Guo L; Jiang F; Li L; Li Z; Chen F
J Cell Mol Med; 2015 Dec; 19(12):2874-87. PubMed ID: 26416600
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA involvement in the pathogenesis and management of breast cancer.
Khoshnaw SM; Green AR; Powe DG; Ellis IO
J Clin Pathol; 2009 May; 62(5):422-8. PubMed ID: 19398594
[TBL] [Abstract][Full Text] [Related]
11. Screening biomarkers of bladder cancer using combined miRNA and mRNA microarray analysis.
Jin N; Jin X; Gu X; Na W; Zhang M; Zhao R
Mol Med Rep; 2015 Aug; 12(2):3170-6. PubMed ID: 25955758
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA Networks in Breast Cancer Cells.
Tahiri A; Aure MR; Kristensen VN
Methods Mol Biol; 2018; 1711():55-81. PubMed ID: 29344885
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA signatures highlight new breast cancer subtypes.
Bhattacharyya M; Nath J; Bandyopadhyay S
Gene; 2015 Feb; 556(2):192-8. PubMed ID: 25485717
[TBL] [Abstract][Full Text] [Related]
14. Global Analysis of miRNA-mRNA Interaction Network in Breast Cancer with Brain Metastasis.
Li Z; Peng Z; Gu S; Zheng J; Feng D; Qin Q; He J
Anticancer Res; 2017 Aug; 37(8):4455-4468. PubMed ID: 28739740
[TBL] [Abstract][Full Text] [Related]
15. Identifying miRNA-mRNA regulatory relationships in breast cancer with invariant causal prediction.
Pham VV; Zhang J; Liu L; Truong B; Xu T; Nguyen TT; Li J; Le TD
BMC Bioinformatics; 2019 Mar; 20(1):143. PubMed ID: 30876399
[TBL] [Abstract][Full Text] [Related]
16. Integrated MicroRNA-mRNA Profiling Identifies Oncostatin M as a Marker of Mesenchymal-Like ER-Negative/HER2-Negative Breast Cancer.
Bottai G; Diao L; Baggerly KA; Paladini L; Győrffy B; Raschioni C; Pusztai L; Calin GA; Santarpia L
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106823
[TBL] [Abstract][Full Text] [Related]
17. Integration of microRNA signatures of distinct mammary epithelial cell types with their gene expression and epigenetic portraits.
Pal B; Chen Y; Bert A; Hu Y; Sheridan JM; Beck T; Shi W; Satterley K; Jamieson P; Goodall GJ; Lindeman GJ; Smyth GK; Visvader JE
Breast Cancer Res; 2015 Jun; 17(1):85. PubMed ID: 26080807
[TBL] [Abstract][Full Text] [Related]
18. MYC and hsa‑miRNA‑423‑5p as biomarkers in nasopharyngeal carcinoma revealed by miRNA‑mRNA‑pathway network integrated analysis.
Tian H; Chen S; Zhang C; Li M; Zheng H
Mol Med Rep; 2017 Aug; 16(2):1039-1046. PubMed ID: 28586063
[TBL] [Abstract][Full Text] [Related]
19. The RNA expression signature of the HepG2 cell line as determined by the integrated analysis of miRNA and mRNA expression profiles.
Bai Y; Xue Y; Xie X; Yu T; Zhu Y; Ge Q; Lu Z
Gene; 2014 Sep; 548(1):91-100. PubMed ID: 25014136
[TBL] [Abstract][Full Text] [Related]
20. Levels of MicroRNA Heterogeneity in Cancer Biology.
Petrovic N; Ergün S; Isenovic ER
Mol Diagn Ther; 2017 Oct; 21(5):511-523. PubMed ID: 28620889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
